Salvage high-dose-rate brachytherapy for local recurrence of prostate cancer

The article describes a successful experience of using high-dose rate brachytherapy (192Ir) in patients with local recurrence of hormone-resistant prostate cancer. High-dose rate brachytherapy allowed to achieve local biochemical control of prostate cancer without toxicity to pelvic organs, thus, maintaining the quality of life. © 2018 ABC-press Publishing House. All rights reserved.

Авторы
Yagudaev D.M. 1, 2 , Kadyrov Z.A. 1 , Kalinin M.R.2 , Bezhenar V.A.2 , Kalyagina N.A.3
Журнал
Издательство
ABC-press Publishing House
Номер выпуска
2
Язык
Русский
Страницы
171-175
Статус
Опубликовано
Том
14
Год
2018
Организации
  • 1 Department of Endoscopic Urology, Faculty of Postgraduate Medical Education, Peoples' Friendship University of Russia, 21/3 Miklukho-Maklaya St., Moscow, 117198, Russian Federation
  • 2 N.A. Semashko Central Clinical Hospital No. 2, Russian Railways Company, 2 Budayskaya St., Moscow, 129128, Russian Federation
  • 3 A.M. Prokhorov General Physics Institute, Russian Academy of Sciences, 38 Vavilova St., Moscow, 119991, Russian Federation
Ключевые слова
192Ir; Castration resistance; Life-saving high-dose rate brachytherapy; Local recurrence; Prostate cancer
Дата создания
19.10.2018
Дата изменения
19.10.2018
Постоянная ссылка
https://repository.rudn.ru/ru/records/article/record/7215/